Literature DB >> 19434825

OSIRIS, an entirely in-house developed drug discovery informatics system.

Thomas Sander1, Joel Freyss, Modest von Korff, Jacqueline Renée Reich, Christian Rufener.   

Abstract

We present OSIRIS, an entirely in-house developed drug discovery informatics system. Its components cover all information handling aspects from compound synthesis via biological testing to preclinical development. Its design principles are platform and vendor independence, a consistent look and feel, and complete coverage of the drug discovery process by custom tailored applications. These include electronic laboratory notebook applications for biology and chemistry, tools for high-throughput and secondary screening evaluation, chemistry-aware data visualization, physicochemical property prediction, 3D-pharmacophore comparisons, interactive modeling, computing grid based ligand-protein docking, and more. Most applications are developed in Java and are built on top of a Java library layer that provides reusable cheminformatics functionality and GUI components such as chemical editors, structure canonicalization, substructure search, combinatorial enumeration, enhanced stereo perception, force field minimization, and conformation generation.

Mesh:

Year:  2009        PMID: 19434825     DOI: 10.1021/ci800305f

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  36 in total

1.  VSDMIP 1.5: an automated structure- and ligand-based virtual screening platform with a PyMOL graphical user interface.

Authors:  Álvaro Cortés Cabrera; Rubén Gil-Redondo; Almudena Perona; Federico Gago; Antonio Morreale
Journal:  J Comput Aided Mol Des       Date:  2011-08-09       Impact factor: 3.686

Review 2.  An Overview of the Challenges in Designing, Integrating, and Delivering BARD: A Public Chemical-Biology Resource and Query Portal for Multiple Organizations, Locations, and Disciplines.

Authors:  Andrea de Souza; Joshua A Bittker; David L Lahr; Steve Brudz; Simon Chatwin; Tudor I Oprea; Anna Waller; Jeremy J Yang; Noel Southall; Rajarshi Guha; Stephan C Schürer; Uma D Vempati; Mark R Southern; Eric S Dawson; Paul A Clemons; Thomas D Y Chung
Journal:  J Biomol Screen       Date:  2014-01-17

3.  Antifungal and anthelmintic activity of novel benzofuran derivatives containing thiazolo benzimidazole nucleus: an in vitro evaluation.

Authors:  R Kenchappa; Yadav D Bodke; Sandeep Telkar; M Aruna Sindhe
Journal:  J Chem Biol       Date:  2016-09-08

Review 4.  Reporting biological assay screening results for maximum impact.

Authors:  Evan Bolton
Journal:  Drug Discov Today Technol       Date:  2015-05-02

5.  Molecular design, synthesis and biological characterization of novel Resveratrol derivative as potential anticancer agent targeting NF-κB.

Authors:  Zuhier Awan; Hussam Ibrahim Kutbi; Aftab Ahmad; Rabbani Syed; Faten A S Alsulaimany; Noor Ahmad Shaik
Journal:  J Appl Biomed       Date:  2020-02-10       Impact factor: 1.797

6.  Lepidium meyenii (Maca) Roots: UPLC-HRMS, Molecular Docking, and Molecular Dynamics.

Authors:  Rana M Ibrahim; Ghada F Elmasry; Rana H Refaey; Riham A El-Shiekh
Journal:  ACS Omega       Date:  2022-05-11

7.  An informatic pipeline for managing high-throughput screening experiments and analyzing data from stereochemically diverse libraries.

Authors:  Carol A Mulrooney; David L Lahr; Michael J Quintin; Willmen Youngsaye; Dennis Moccia; Jacob K Asiedu; Evan L Mulligan; Lakshmi B Akella; Lisa A Marcaurelle; Philip Montgomery; Joshua A Bittker; Paul A Clemons; Stephen Brudz; Sivaraman Dandapani; Jeremy R Duvall; Nicola J Tolliday; Andrea De Souza
Journal:  J Comput Aided Mol Des       Date:  2013-04-13       Impact factor: 3.686

8.  Novel Heteroaryl Selenocyanates and Diselenides as Potent Antileishmanial Agents.

Authors:  Ylenia Baquedano; Verónica Alcolea; Miguel Ángel Toro; Killian Jesús Gutiérrez; Paul Nguewa; María Font; Esther Moreno; Socorro Espuelas; Antonio Jiménez-Ruiz; Juan Antonio Palop; Daniel Plano; Carmen Sanmartín
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

9.  Development of piperazine-1-carbothioamide chitosan silver nanoparticles (P1C-Tit*CAgNPs) as a promising anti-inflammatory candidate: a molecular docking validation.

Authors:  C S Karthik; H M Manukumar; S Sandeep; B L Sudarshan; S Nagashree; L Mallesha; K P Rakesh; K R Sanjay; P Mallu; Hua-Li Qin
Journal:  Medchemcomm       Date:  2018-04-04       Impact factor: 3.597

10.  Novel phytochemical-antibiotic conjugates as multitarget inhibitors of Pseudomononas aeruginosa GyrB/ParE and DHFR.

Authors:  Premkumar Jayaraman; Kishore R Sakharkar; ChuSing Lim; Mohammad Imran Siddiqi; Sarinder K Dhillon; Meena K Sakharkar
Journal:  Drug Des Devel Ther       Date:  2013-06-17       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.